Abstract:Conotoxins (CTxs) selectively target a range of ion channels and receptors, making them widely used tools for probing nervous system function. Conotoxins have been previously grouped into superfamilies according to signal sequence and into families based on their cysteine framework and biological target. Here we describe the cloning and characterization of a new conotoxin, from Conus vexillum, named αB-conotoxin VxXXIVA. The peptide does not belong to any previously described conotoxin superfamily and its arrangement of Cys residues is unique among conopeptides. Moreover, in contrast to previously characterized conopeptide toxins, which are expressed initially as prepropeptide precursors with a signal sequence, a ''pro'' region, and the toxin-encoding region, the precursor sequence of αB-VxXXIVA lacks a ''pro'' region. The predicted 40-residue mature peptide, which contains four Cys, was synthesized in each of the three possible disulfide arrangements. Investigation of the mechanism of action of αB-VxXXIVA revealed that the peptide is a nicotinic acetylcholine receptor (nAChR) antagonist with greatest potency against the α9α10 subtype. (1)H nuclear magnetic resonance (NMR) spectra indicated that all three αB-VxXXIVA isomers were poorly structured in aqueous solution. This was consistent with circular dichroism (CD) results which showed that the peptides were unstructured in buffer, but adopted partially helical conformations in aqueous trifluoroethanol (TFE) solution. The α9α10 nAChR is an important target for the development of analgesics and cancer chemotherapeutics, and αB-VxXXIVA represents a novel ligand with which to probe the structure and function of this protein.

Structure and Activity Studies of Disulfide-Deficient Analogues of Αo-Conotoxin GeXIVA.

Structure-Activity Relationships of Alanine Scan Mutants O-Conotoxins GeXIVA[1,2] and GeXIVA[1,4]

Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA and GeXIVA

Cloning, Synthesis, and Characterization of Αo-Conotoxin GeXIVA, a Potent Α9α10 Nicotinic Acetylcholine Receptor Antagonist

Αo-Conotoxin GeXIVA Disulfide Bond Isomers Exhibit Differential Sensitivity for Various Nicotinic Acetylcholine Receptors but Retain Potency and Selectivity for the Human Α9α10 Subtype

Dual Antagonism of Α9α10 Nachr and GABAB Receptor-Coupled CaV2.2 Channels by an Analgesic Αo-Conotoxin Analogue.

Aspartic acid mutagenesis of αO-Conotoxin GeXIVA isomers reveals arginine residues crucial for inhibition of the α9α10 nicotinic acetylcholine receptor

Conotoxin Αd-Gexxa Utilizes a Novel Strategy to Antagonize Nicotinic Acetylcholine Receptors.

Anti-hypersensitive Effect of Intramuscular Administration of Αo-Conotoxin GeXIVA[1,2] and GeXIVA[1,4] in Rats of Neuropathic Pain

Novel Αo-Conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment.

Dual Antagonism of α9α10 nAChR and GABA B Receptor-Coupled Ca V 2.2 Channels by an Analgesic αO-Conotoxin Analogue

Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic Α-Conotoxin Vc1.1

N-Terminal Capping of the αO-Conotoxin Analogue GeX-2 Improves the Serum Stability and Selectivity toward the Human α9α10 Nicotinic Acetylcholine Receptor

Effects of Serum, Enzyme, Thiol, and Forced Degradation on the Stabilities of Αo‐conotoxin GeXIVA[1,2] and GeXIVA [1,4]

Role of CysI–CysIII Disulfide Bond on the Structure and Activity of Α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors

Influence of Disulfide Connectivity on Structure and Bioactivity of Α-Conotoxin TxIA

A Novel Lid-Covering Peptide Inhibitor of Nicotinic Acetylcholine Receptors Derived from Αd-Conotoxin GeXXA.

Synthesis and evaluation of disulfide-rich cyclic -conotoxin [S9A]TxID analogues as novel 3134 nAChR antagonists

A Novel Inhibitor of Α9α10 Nicotinic Acetylcholine Receptors from Conus Vexillum Delineates a New Conotoxin Superfamily.

Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists

Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors